ROBERT STAGGS: Open Payments
NPI 1346254570 · HUTCHINSON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$594 in 32 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $307 · 2025 $594
Food & beverage: $594
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $157 |
| Novo Nordisk Inc | 4 | $78 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| Lundbeck LLC | 3 | $58 |
| Paratek Pharmaceuticals, Inc. | 2 | $38 |
| Xeris Pharmaceuticals, Inc. | 2 | $36 |
| Amgen Inc. | 2 | $34 |
| PFIZER INC. | 2 | $33 |
| Dexcom, Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $20 |
Products named: REXULTI, VRAYLAR, NUZYRA, KEVEYIS, OTEZLA, Dexcom G6 Transmitter, Ozempic, MAVYRET.
Industry payments across KS — which companies pay providers there.
